Figure 1. Research Method Flow Chart 10
Figure 2. Breakdown of Primary Research 12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 16
Figure 5. Europe Virus Filtration Market, 2019-2026, $ mn 18
Figure 6. Impact of COVID-19 on Business 22
Figure 7. Primary Drivers and Impact Factors of Europe Virus Filtration Market 24
Figure 8. Primary Restraints and Impact Factors of Europe Virus Filtration Market 27
Figure 9. Investment Opportunity Analysis 31
Figure 10. Porter’s Fiver Forces Analysis of Europe Virus Filtration Market 34
Figure 11. Breakdown of Europe Virus Filtration Market by Product, 2019-2026, % of Revenue 38
Figure 12. Contribution to Europe 2020-2026 Cumulative Revenue by Product, Value ($ mn) and Share (%) 39
Figure 13. Europe Virus Filtration Market: Consumables, 2016-2026, $ mn 40
Figure 14. Europe Virus Filtration Market: Instruments, 2016-2026, $ mn 41
Figure 15. Europe Virus Filtration Market: Filtration Systems, 2016-2026, $ mn 42
Figure 16. Europe Virus Filtration Market: Chromatography systems, 2016-2026, $ mn 43
Figure 17. Europe Virus Filtration Market: Services, 2016-2026, $ mn 44
Figure 18. Breakdown of Europe Virus Filtration Market by Application, 2019-2026, % of Revenue 45
Figure 19. Contribution to Europe 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 46
Figure 20. Europe Virus Filtration Market: Biological Applications, 2016-2026, $ mn 47
Figure 21. Europe Virus Filtration Market: Vaccines and Therapeutics, 2016-2026, $ mn 49
Figure 22. Europe Virus Filtration Market: Blood and Blood Products, 2016-2026, $ mn 50
Figure 23. Europe Virus Filtration Market: Cellular and Gene Therapy Products, 2016-2026, $ mn 51
Figure 24. Europe Virus Filtration Market: Tissue and Tissue Products, 2016-2026, $ mn 52
Figure 25. Europe Virus Filtration Market: Stem Cell Products, 2016-2026, $ mn 53
Figure 26. Europe Virus Filtration Market: Medical Devices, 2016-2026, $ mn 54
Figure 27. Europe Virus Filtration Market: Water Purification, 2016-2026, $ mn 55
Figure 28. Europe Virus Filtration Market: Air Purification, 2016-2026, $ mn 56
Figure 29. Europe Virus Filtration Market: Other Applications, 2016-2026, $ mn 57
Figure 30. Breakdown of Europe Virus Filtration Market by End User, 2019-2026, % of Revenue 59
Figure 31. Contribution to Europe 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%) 59
Figure 32. Europe Virus Filtration Market: Pharmaceutical and Biotechnology Companies, 2016-2026, $ mn 60
Figure 33. Europe Virus Filtration Market: Contract Research Organisations (CROs), 2016-2026, $ mn 61
Figure 34. Europe Virus Filtration Market: Academic & Research Institutes, 2016-2026, $ mn 62
Figure 35. Europe Virus Filtration Market: Medical Device Companies, 2016-2026, $ mn 63
Figure 36. Europe Virus Filtration Market: Other End Users, 2016-2026, $ mn 64
Figure 37. Breakdown of European Virus Filtration Market by Country, 2019 and 2026, % of Revenue 66
Figure 38. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 67
Figure 39. Virus Filtration Market in UK, 2016-2026, $ mn 68
Figure 40. Virus Filtration Market in France, 2016-2026, $ mn 70
Figure 41. Virus Filtration Market in Germany, 2016-2026, $ mn 72
Figure 42. Virus Filtration Market in Spain, 2016-2026, $ mn 74
Figure 43. Virus Filtration Market in Italy, 2016-2026, $ mn 76
Figure 44. Virus Filtration Market in Russia, 2016-2026, $ mn 78
Figure 45. Virus Filtration Market in Rest of Europe, 2016-2026, $ mn 80
Figure 46. Growth Stage of Europe Virus Filtration Industry over the Forecast Period 82
Table 1. Snapshot of Europe Virus Filtration Market in Balanced Perspective, 2019-2026 17
Table 2. Growth Rate of World Real GDP, 2017-2021 20
Table 3. Main Product Trends and Market Opportunities in Europe Virus Filtration Market 30
Table 4. Europe Virus Filtration Market by Product, 2016-2026, $ mn 38
Table 5. Europe Virus Filtration Market: Instruments by Technology, 2016-2026, $ mn 41
Table 6. Europe Virus Filtration Market by Application, 2016-2026, $ mn 45
Table 7. Europe Virus Filtration Market: Biological Applications by Segment, 2016-2026, $ mn 48
Table 8. Europe Virus Filtration Market by End User, 2016-2026, $ mn 58
Table 9. Europe Virus Filtration Market by Country, 2016-2026, $ mn 67
Table 10. UK Virus Filtration Market by Product, 2016-2026, $ mn 69
Table 11. UK Virus Filtration Market by Application, 2016-2026, $ mn 69
Table 12. UK Virus Filtration Market by End User, 2016-2026, $ mn 69
Table 13. France Virus Filtration Market by Product, 2016-2026, $ mn 71
Table 14. France Virus Filtration Market by Application, 2016-2026, $ mn 71
Table 15. France Virus Filtration Market by End User, 2016-2026, $ mn 71
Table 16. Germany Virus Filtration Market by Product, 2016-2026, $ mn 73
Table 17. Germany Virus Filtration Market by Application, 2016-2026, $ mn 73
Table 18. Germany Virus Filtration Market by End User, 2016-2026, $ mn 73
Table 19. Spain Virus Filtration Market by Product, 2016-2026, $ mn 75
Table 20. Spain Virus Filtration Market by Application, 2016-2026, $ mn 75
Table 21. Spain Virus Filtration Market by End User, 2016-2026, $ mn 75
Table 22. Italy Virus Filtration Market by Product, 2016-2026, $ mn 77
Table 23. Italy Virus Filtration Market by Application, 2016-2026, $ mn 77
Table 24. Italy Virus Filtration Market by End User, 2016-2026, $ mn 77
Table 25. Russia Virus Filtration Market by Product, 2016-2026, $ mn 79
Table 26. Russia Virus Filtration Market by Application, 2016-2026, $ mn 79
Table 27. Russia Virus Filtration Market by End User, 2016-2026, $ mn 79
Table 28. Virus Filtration Market in Rest of Europe by Country, 2016-2026, $ mn 81
Table 29. Asahi Kasei Medical Co., Ltd.: Company Snapshot 86
Table 30. Asahi Kasei Medical Co., Ltd.: Business Segmentation 86
Table 31. Asahi Kasei Medical Co., Ltd.: Product Portfolio 87
Table 32. Asahi Kasei Medical Co., Ltd.: Revenue, 2016-2018, $ mn 87
Table 33. Asahi Kasei Medical Co., Ltd.: Recent Developments 87
Table 34. Risk Evaluation for Investing in Europe Market, 2019-2026 99
Table 35. Critical Success Factors and Key Takeaways 102
Safe and Secure SSl Encryption
Licensing options
2480
USD
You can select one of these options upon checking out
Allows one individual to access the purchased report
Allows up to five individuals to access the purchased report
Allows all employees of an organization to access the purchased report. Internal sharing only
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral
North America: +1 201 793 8545 Europe: +44 20 8089 0049 Asia-Pacific: +91 7878231309
Email us on:- sales@bonafideresearch.com
Order Placed (28 May, 2023)
Notify To Team (28 May, 2023)
Report updation (29 May, 2023)
Report Quality Check (29 May, 2023)
Report Dispatch (30 May, 2023)
Hard Copy
Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer $1000 worth of FREE customization at the time of purchase
80% of the clinet request tailor made solution, how can we help you?
Avail customized purchase options to meet your exact research needs:
READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.
CEO
Vivek Arora
BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!
EXECUTIVE DIRECTOR
Rahul Roy
THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.
SALES DIRECTOR
Arjun Prasad
THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH
President
Manish Verma
Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
MARKETING DIRECTOR
Gautam Saxena
The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.
PRODUCT MANAGER
Tom Stone
I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.
Associate Director
Mark Wood
Europe virus filtration market accounted for $696.7 million in 2019 and will grow by 11.34% annually over 2020-2026 owing to the rapid growth of pharmaceutical and biotechnology industry, increasing investments in R&D, surging need for virus removal and clearance amid COVID-19 pandemic. Highlighted with 35 tables and 46 figures, this 104-page report “Europe Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire Europe virus filtration market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe virus filtration market in every aspect of the classification from perspectives of Product, Application, End User, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. Consumables Instruments • Filtration Systems • Chromatography systems Services Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. Biological Applications • Vaccines and Therapeutics • Blood and Blood Products • Cellular and Gene Therapy Products • Tissue and Tissue Products • Stem Cell Products Medical Devices Water Purification Air Purification Other Applications Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. • Pharmaceutical and Biotechnology Companies • Contract Research Organisations (CROs) • Academic & Research Institutes • Medical Device Companies • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Europe virus filtration market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Asahi Kasei Medical Co., Ltd. Charles River Laboratories International, Inc. Clean Cells General Electric Company Lonza Group AG Merck KGaA MilliporeSigma Pall Corporation Sartorius AG Thermo Fisher Scientific, Inc. Wuxi Apptec (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More